Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
cancer - search results
If you're not happy with the results, please do another search
Development of novel therapies for pediatric cancer: Successes and challenges
Peter J. Houghton from Greehey Children’s Cancer Research Institute and Mary-Ann Bjornsti from the University of Alabama discuss some of the key challenges in the development of therapies for pediatric cancer care.
Scientists record a decline in cancer related deaths among rising cancer cases
New research looks at cancer cases in the UK, revealing complex factors driving progress and challenges.
Drug development could help treat one of the most challenging cancers
A new drug development could help those battling pancreatic cancer, one of the most challenging cancers to treat.
Engineered endosymbionts as novel cancer therapeutics
Satyajit Hari Kulkarni and Christopher H. Contag from the Institute for Quantitative Health Science and Engineering focus on engineered endosymbionts, which they argue is a paradigm shift in anticancer bacteriotherapy toward killing tumors from the inside out.
Predicting improved response to lung cancer immunotherapy
Researchers have identified 140 genes that could change how non-small cell lung cancer (NSCLC) patients are treated with immunotherapy and low-dose radiation.
World Cancer Day: Digital cancer care to address UK inequity
Paul Landau, CEO of Careology, a digital cancer care platform used by the NHS and private health sector, posits the need for smart investment into digital tools to support cancer care and maximise the efficiency of resources.
AI cancer treatment: AI tool to enhance precision for cancer treatment
A new cutting-edge artificial intelligence tool has been developed to revolutionise cancer treatment.
People-centred health services are essential to reducing disparities in cancer care
The past ten years have seen significant progress in cancer care, detecting cancers earlier and managing them more successfully and less invasively on a global scale.
Skin cancer mutation offers hope for healing broken hearts
Is there a way to mend a broken heart? Biomedical engineers have found a potential way to mend a broken heart using a genetic mutation commonly associated with skin cancers.
The non-invasive cancer-grade probing system
Researchers have introduced a non-invasive method for determining the malignancy grade of glioma tumours.
AI unlocks cancer treatment secrets
Using artificial intelligence, scientists have tackled one of the toughest challenges in cancer research.
Researchers reveal blood cell traits influence risk of rare blood cancer
Scientists have revealed how common variations in our blood cells can act as unexpected allies to cancer-causing mutations.
Unraveling the potential of antisense therapies to target neuropilin 1 in the fight against...
Secarna Pharmaceuticals, the next-generation antisense drug discovery and development company, is developing novel approaches to successfully target Neuropilin 1 (NRP1), a promising target for the treatment of cancer.
Secarna aims to expand the therapeutic toolbox against cancer
Current oncology treatments have significantly improved cancer survival rates, but more effective and safer therapeutics are needed.
Daily exercise linked to prolonged life in inoperable lung cancer
A life-extending link has been discovered between minimum physical activity and inoperable lung cancer.
Enhancing cancer care through genomic testing
Simon Holt, Honorary Professor at Swansea University, reflects on the key challenges within cancer care and the benefits of genomic testing in improving patient outcomes.
Consuming ultra-processed foods associated with elevated cancers
Consuming higher-quality ultra-processed foods (UPFs) might be linked to a higher risk of cancers in the upper aerodigestive tract, encompassing the mouth, throat, and oesophagus.
Identifying lung cancer risk in ‘never smokers’ using artificial intelligence
An artificial intelligence tool can effectively detect high-risk individuals for lung cancer among non-smokers using routine chest X-ray images.
From byte to bedside: Ushering in the era of digital oncology to outsmart cancer
Philip Dunne and Mark Lawler from the Patrick G Johnston Centre for Cancer Research talk to us about the emerging field of ‘digital oncology’ and how their approach can truly optimise cancer research and care.
